(In the Media) “Clinical Trials Using Cancer Treatment for Terminal Nerve Disease「Doctor Led Clinical Trials」Complex Processes Hinder Establishment” (Sankei Shimbun, November 5, 2014) (in Japanese)
date : 11/5/2014
An interview with HGPI’s Executive Director, Toshio Miyata, was featured in the following article:
“Clinical Trials Using Cancer Treatment for Terminal Nerve Disease「Doctor Led Clinical Trials」Complex Processes Hinder Establishment”
(Sankei Shimbun, November 5, 2014) (in Japanese)
「神経の難病に抗がん剤治験「医師主導治験」手続き煩雑で定着せず」
“Clinical Trials Using Cancer Treatment for Terminal Nerve Disease「Doctor Led Clinical Trials」Complex Processes Hinder Establishment”
(Sankei Shimbun, November 5, 2014) (in Japanese)
「神経の難病に抗がん剤治験「医師主導治験」手続き煩雑で定着せず」
Top Research & Recommendations Posts
Featured Posts
-
2026-08-05
[Registration Open] (Webinar) The 4th J-PEP Seminar “The History of PPI in Japan and My Own PPI Journey” (September 30, 2026)
-
2026-08-28
[Announcement] The 3rd Kiyoshi Kurokawa Award: Call for Nominations (Deadline: October 1, 2026)
-
2026-09-01
[Registration Open] HGPI Salon 2025-2026 Looking Ahead to the Future of Japan’s Social Security System “Session 6: Japan’s Health Policy through the Lens of Global Security” (October 13, 2026)
-
2026-09-17
[Registration Open] (Webinar) The 145th HGPI Seminar “Toward Better AMR Measures at Elderly Care Facilities—Considering Infectious Disease Control in a Super-Aged Society From a Policy Perspective” (October 27, 2026)



